Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.

Poenisch, Wolfram

Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma. [electronic resource] - Journal of cancer research and clinical oncology Nov 2015 - 2013-22 p. digital

Publication Type: Journal Article

1432-1335

10.1007/s00432-015-1984-4 doi


Adult
Aged
Antineoplastic Agents, Alkylating--therapeutic use
Antineoplastic Agents, Hormonal--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bendamustine Hydrochloride--therapeutic use
Blood Component Removal
Bortezomib--therapeutic use
Disease-Free Survival
Female
Hematopoietic Stem Cell Mobilization--adverse effects
Hematopoietic Stem Cell Transplantation--adverse effects
Humans
Male
Middle Aged
Multiple Myeloma--therapy
Prednisone--therapeutic use
Retrospective Studies
Transplantation Conditioning
Transplantation, Autologous--adverse effects